As of April 16, 2025, Krystal Biotech (KRYS) has a market cap of $4.89 billion USD. According to our data, Krystal Biotech is ranked No.2581 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $4.89 B |
8.48%
|
Dec 31, 2024 | $4.51 B |
26.28%
|
Dec 29, 2023 | $3.57 B |
56.60%
|
Dec 30, 2022 | $2.28 B |
13.25%
|
Dec 31, 2021 | $2.01 B |
16.58%
|
Dec 31, 2020 | $1.73 B |
8.34%
|
Dec 31, 2019 | $1.59 B |
166.51%
|
Dec 31, 2018 | $0.60 B |
97.53%
|
Dec 29, 2017 | $0.30 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Boundless Bio
BOLD
|
$30.11 M |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() MaxCyte
MXCT
|
$0.28 B |
-0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Solid Biosciences
SLDB
|
$0.21 B |
0.000 M
|
![]() USA
|
![]() Genprex
GNPX
|
$6.28 M |
0.000 M
|
![]() USA
|
Market Cap | = | KRYS Stock Price | * | KRYS Shares Outstanding |
= | $169.13 | * | 28.90 M | |
= | $4.89 B |